🕹️ A game with a scientific twist? Prague has one. Mission Retrovirus is a new outdoor game in Dejvice inspired by Czech antiviral research and the legacy of Antonín Holý. Play outdoors or online. Good news: from September, the game will also be available in English. www.uochb.cz/cs/novinky/8...

Nová outdoorová hra představuje český výzkum antivirotik

Pátrání po zmizelém profesorovi, luštění tajných zpráv i hledání převratného léčiva. Outdoorová hra Mise Retrovirus se odehrává v pražských Dejvicích a přibližuje český výzkum, který stál u zrodu…

uochb.cz

What biological question would you ask if feasibility were not the first constraint? The new #DreamBiologyAward by IOCB Prague invites young scientists to submit ambitious life science visions — bold ideas with originality, depth, and long-term impact at their core. More info: dreambiologyaward.org

Background in life sciences and thinking about how to move closer to business, leadership, and innovation? Applications for the 2nd edition of the Prague.bio Executive Academy are open until 31 July. More info and application: prague.bio/academy/ #LifeSciences #Biotech #ExecutiveAcademy

Czech biotech stands on stronger foundations than many still assume. Nearly 430 entities, CZK 97.5bn in annual revenue, and growing investor attention show real momentum. But further growth will depend on one thing: turning strong science into investable, scalable projects. #Biotech #Czechia

Boston is not just a location. It is a concentration of capital, experience, and decision-making. For Central European projects, that is not an abstract benchmark, but a different operating environment. Through IOCB Boston, we are already part of that ecosystem. #Biotech #TechTransfer #Boston

Join us at #BioEquity Europe 2026 for the Regional Host Panel: How to Bring Great Science to Market – The CEE Case. Julie Proft will join the discussion, moderated by Zuzana Válková, on what makes CEE science investable and how the region can build stronger biotech success. 📅 5 May 🕓 4:00 pm

Thank you very much to the @biovaria.bsky.social team for a great #BioVaria 2026. see you next year for #BioVaria2027 #innovation #BioTech

The afternoon session @biovaria.bsky.social 2026 is filled with 3 projects developed at @iocbprague.bsky.social - The SQM - Quantum Mechanical Scoring is starting off the trio. The team has already 3 Pharma partners & looking for more #BioVaria2026 #innovation #BioTech

Gasdermin inhibitors for the treatment of #stroke. A #smallmolecule program from #LDC & #KHANH presented @biovaria.bsky.social

@bihatcharite.bsky.social is opening the scientific part of #BioVaria2026 - Genome editing for the cure of #PR3-AAC patients. #techtransfer #innovation #biovaria

And so it starts @biovaria.bsky.social 2026. Looking forward to great technologies, interesting talks & networking. AND our yearly BlueSky battle #BioVaria2026 #techtransfer #innovation

Not every important step in life sciences starts with a new concept. Sometimes, it comes from making existing methods work better. Great to see LAM-X develop VerdiBlot and continue precise work on nanomaterials — thoughtful innovation in a part of science that often stays out of the spotlight.

Bio€quity Europe is almost here! From 4–6 May 2026, Prague will welcome investors, biotech companies, and tech transfer professionals for several days of partnering and discussion. For IOCB Tech, it is an important space where research, investment, and application meet. #BioEquity #Biotech

Some of the most important advances in life sciences are tools, not therapies. Great to see LAM-X introduce VerdiBlot, a new bioanalytical method building on Western blot with the aim of making protein analysis more reliable and easier to interpret. Congrats. #Bioanalysis #LifeSciences

Czechia is not lagging in research investment. Around 2% of GDP goes into R&D, and the scientific base is strong. The challenge is what comes next: turning research into companies, products, and market presence. That is where IOCB Tech works. #TechTransfer #Innovation

🇵🇹 We’re delighted to be at BIO-Europe Spring in beautiful Lisbon, Portugal, alongside our colleagues from Prague.bio Come and meet us at BOOTH 73. 🤝🧬 #BIOEuropeSpring #Lisbon #Biotech #LifeSciences #Networking #Innovation

🎧 Today’s podcast tip: Our colleague Martin Kovalčík from i&i Prague interviewed Jan Berka, who helps develop the portfolio of i&i Prague projects, in a new episode of #ChemagazinTalks. 👉 Link in comments 📷 Photo: i&i Prague #Biotech #Podcast #TechTransfer

“Who owns the work an AI produces — and how safe is our data, really?” 🤖 That’s why Matěj Malý and Kateřina Habelová joined a seminar at the Prague Innovation Institute on IP, AI & ethics in research (Feb 25), including what the European AI Act will mean in practice. 📷 Prague Innovation Institute

Today, we’re happy to spotlight Jana Kenney — Analyst & Project Manager at IOCB Tech. 👤🧬 Jana brings a sharp analytical mindset and a great feel for what it takes to move projects forward beyond the lab. #MeetTheTeam #IOCBTech #LifeSciences #TechnologyTransfer #TechTransfer #Biotech

🧬 Metabolism research is moving fast toward clinical impact — proud to support the Prague Metabolism & Signaling Symposium. More soon! #MetabolismSymposium (via @PragueMetabol on X)

Should biotech stay in the lab — or also help strengthen Europe’s security? 🛡️ 💬 “Given today’s geopolitics, we in biotech can’t ignore stability and safety,” says Matěj Malý (IOCB Tech). Feb 17: Czech Industry Day + EDF matchmaking. 🤝 🔗 lnkd.in/dzt93UFs #Biotech #Defence #EDF #Innovation

Throwback to our Czech delegation at BioVaria 2025 🇨🇿 Proud that IOCB Tech is a Power Partner of BioVaria 2026 — we’ll be back in Munich on 27–28 Apr.📍 A curated showcase of dozens of licensable life-science technologies + selected start-ups, with partnering that actually leads to follow-ups.🤝

📬 Worth a quick read: Press 13 (January 2026) from the Harvard Innovation Labs. And it’s also a good reminder why it matters that Ústav organické chemie a biochemie AV ČR has a presence in Boston through IOCB Boston 🇺🇸🔬 👉 Read the newsletter: lnkd.in/dkWJ9KJp #Boston #Cambridge #Innovation

📅 For anyone keeping an eye on what’s next in biotech, these dates are worth marking in your calendar in 2026 — they’re already in ours, and we look forward to engaging with many of you along the way. 🔗 Links in the comments ⬇️ #TechTransfer #LifeSciences #Biotech #Events2026

🇱🇺 In Luxembourg, Petr Zelenka’s Elegance of the Molecule opened a window into the moment when a scientific idea first takes shape — inspired by discoveries of Czech chemist Antonín Holý. It’s a reminder for Europe’s innovators to keep an eye on the new stories emerging in Czechia. #TechTransfer

Science met theatre last night in Luxembourg — and the result was a powerful reminder of how stories shape discovery. The Elegance of the Molecule by Dejvické divadlo brought researchers, actors, founders and diplomats onto one stage — and into one storyworld. #LifeSciences #TechTransfer #Luxembourg

✨It’s official: Julie Proft is stepping into the role of Deputy Director of IOCB Tech. Julie has been part of IOCB Tech since 2016 and brings a rare combination of scientific insight, international experience, and a keen sense for how technology transfer works in practice. #MeetTheTeam #TechTransfer

What does leadership built on experience and driven by a commitment to excellence look like? Meet Milan Prášil, CEO of IOCB Tech — the first profile in our new #MeetTheTeam series. #TechTransfer #LifeSciences #Innovation

We will be there, will you? #boston Join us for an evening of introductions, excitement, and chemistry that makes a difference — bridging discovery and medicine, Prague and Boston, ideas and action. Read the full post by #IOCBBoston on LinkedIn⤵️: www.linkedin.com/company/5093...

“My dream is to capture air and separate air to - for instance, in CO₂ or oxygen or water or something - and convert this to useful materials using renewable energy.” 🧬Susumu Kitagawa, Nobel Prize 2025 At IOCB Tech we believe that science finds its true voice when it speaks beyond the lab.